首页 › 基金 › Bain Capital Life Sciences Investors, LLC › KYTX
Bain Capital Life Sciences Investors, LLC 对 KYTX 的持仓历史
KYVERNA THERAPEUTICS INC · 医疗保健
Bain Capital Life Sciences Investors, LLC 在 Q3 2026 的 13F 申报中披露持有 KYTX(KYVERNA THERAPEUTICS INC)1,312,000 股,市值约 US$8.9M,约占其申报组合的 0.61%,在其申报持仓中市值排名第 19 位。 Bain Capital Life Sciences Investors, LLC 最近 11 个申报季度中有 11 个季度披露了 KYTX 持仓,最早可追溯至 Q1 2024。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Bain Capital Life Sciences Investors, LLC 对 KYTX 的持仓演变
Bain Capital Life Sciences Investors, LLC 于 Q1 2024 首次披露 KYTX 持仓:3,163,868 股(约 US$78.6M)。 在 11 次申报中,Bain Capital Life Sciences Investors, LLC 1 次增持、3 次减持、6 次保持不变。 最近一期申报(Q3 2026)显示持股 1,312,000 股、市值约 US$8.9M,环比减持 -1,573,000 股。。 持仓曾出现大幅变动:Q3 2026 减持约 55% (随后一个季度股价下跌 26%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2024 | 3.16M | $78.59M | 新进 |
| Q2 2024 | 3.37M | $25.26M | 增持 |
| Q3 2024 | 3.37M | $16.47M | 持有 |
| Q4 2024 | 3.37M | $12.60M | 持有 |
| Q1 2025 | 3.37M | $6.50M | 持有 |
| Q2 2025 | 3.37M | $10.34M | 持有 |
| Q3 2025 | 3.37M | $20.21M | 持有 |
| Q4 2025 | 3.11M | $29.23M | 减持 |
| Q1 2026 | 3.11M | $26.84M | 持有 |
| Q2 2026 | 2.88M | $25.71M | 减持 |
| Q3 2026 | 1.31M | $8.92M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 KYTX 与 13F 数据
KYTX(KYVERNA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 39 只申报持有 KYTX,申报仓位最大的包括:GordonMD Global Investments LP (US$30.7M), GILEAD SCIENCES, INC. (US$28.1M), AIGH Capital Management LLC (US$24.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 KYTX 的基金
- GordonMD Global Investments LP 4.52M 股 · $30.74M · Q3 2026
- GILEAD SCIENCES, INC. 4.13M 股 · $28.06M · Q3 2026
- AIGH Capital Management LLC 3.65M 股 · $24.82M · Q3 2026
- Insight Holdings Group, LLC 989.05K 股 · $8.81M · Q2 2026
- MBB PUBLIC MARKETS I LLC 614.48K 股 · $5.47M · Q2 2026
- Propel Bio Management, LLC 700.60K 股 · $4.76M · Q3 2026
更多关于 Bain Capital Life Sciences Investors, LLC
常见问题
How long has Bain Capital Life Sciences Investors, LLC held KYTX?
Bain Capital Life Sciences Investors, LLC has disclosed KYTX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Bain Capital Life Sciences Investors, LLC's current position in KYTX?
As of Q3 2026, Bain Capital Life Sciences Investors, LLC holds 1.31M shares of KYTX (KYVERNA THERAPEUTICS INC), valued at $8.92M, representing 0.61% of its reported portfolio and ranking #19.
Has Bain Capital Life Sciences Investors, LLC been buying or selling KYTX?
In the latest 13F filing (Q3 2026), Bain Capital Life Sciences Investors, LLC reduced its position in KYTX.
Which other funds hold KYTX?
Other major institutional holders of KYTX include GordonMD Global Investments LP, GILEAD SCIENCES, INC., AIGH Capital Management LLC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.